TY - JOUR
T1 - Socio-Economic Burden of Myocardial Infarction Among Cancer Patients
AU - Guha, Avirup
AU - Dey, Amit Kumar
AU - Al-Kindi, Sadeer
AU - Miller, P. Elliott
AU - Ghosh, Arjun K.
AU - Banerjee, Amitava
AU - Lopez-Mattei, Juan
AU - Desai, Nihar R.
AU - Patel, Brijesh
AU - Oliveira, Guilherme H.
AU - de Lima, Marcos
AU - Fradley, Michael
AU - Addison, Daniel
PY - 2021/2/15
Y1 - 2021/2/15
N2 - Cancer patients face a higher risk of future myocardial infarction (MI), even after completion of anticancer therapies. MI is a critical source of physical and financial stress in noncancer patients, but its impacts associated with cancer patients also saddled with the worry (stress) of potential reoccurrence is unknown. Therefore, we aimed to quantify MI's stress and financial burden after surviving cancer and compare to those never diagnosed with cancer. Utilizing cross-sectional national survey data from 2013 to 2018 derived from publicly available United States datasets, the National Health Interview Survey, and economic data from the National Inpatient Sample, we compared the socio-economic outcomes in those with MI by cancer-status. We adjusted for social, demographic, and clinical factors. Overall, 19,504 (10.2%) of the 189,836 National Health Interview Survey responders reported having cancer for more than 1 year. There was an increased prevalence of MI in cancer survivors compared with noncancer patients (8.8% vs 3.2%, p 0.05). There was no difference in annual residual family income by cancer status; however, 3 lowest deciles of residual income representing 21.1% cancer-survivor with MI had a residual income of
AB - Cancer patients face a higher risk of future myocardial infarction (MI), even after completion of anticancer therapies. MI is a critical source of physical and financial stress in noncancer patients, but its impacts associated with cancer patients also saddled with the worry (stress) of potential reoccurrence is unknown. Therefore, we aimed to quantify MI's stress and financial burden after surviving cancer and compare to those never diagnosed with cancer. Utilizing cross-sectional national survey data from 2013 to 2018 derived from publicly available United States datasets, the National Health Interview Survey, and economic data from the National Inpatient Sample, we compared the socio-economic outcomes in those with MI by cancer-status. We adjusted for social, demographic, and clinical factors. Overall, 19,504 (10.2%) of the 189,836 National Health Interview Survey responders reported having cancer for more than 1 year. There was an increased prevalence of MI in cancer survivors compared with noncancer patients (8.8% vs 3.2%, p 0.05). There was no difference in annual residual family income by cancer status; however, 3 lowest deciles of residual income representing 21.1% cancer-survivor with MI had a residual income of
UR - https://www.mendeley.com/catalogue/0a103e84-dc4f-3eaf-837f-73a1b2462a7b/
U2 - 10.1016/j.amjcard.2020.11.005
DO - 10.1016/j.amjcard.2020.11.005
M3 - Article
C2 - 33217349
SN - 0002-9149
VL - 141
SP - 16
EP - 22
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -
